RTC
ELV icon

Riverview Trust Company’s Elevance Health ELV Stock Holding History

Riverview Trust Company’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-72
Closed -$31.3K – 325
2025
Q1 		$31.3K Buy
72
+67
+1,340% +$26.9K 0.03% 293
2024
Q4 		$1.84K Sell
5
-121
-96% -$50.6K ﹤0.01% 596
2024
Q3 		$65.5K Buy
126
+4
+3% +$2.14K 0.06% 207
2024
Q2 		$66.1K Hold
122
– – 0.06% 188
2024
Q1 		$63.3K Buy
+122
New +$60.7K 0.05% 214
2023
Q4 		– Sell
-122
Closed -$53.1K – 256
2023
Q3 		$53.1K Hold
122
– – 0.05% 227
2023
Q2 		$54.2K Sell
122
-59
-33% -$27.2K 0.05% 197
2023
Q1 		$83.2K Hold
181
– – 0.08% 158
2022
Q4 		$93K Buy
181
+27
+18% +$13.7K 0.09% 149
2022
Q3 		$70K Buy
154
+32
+26% +$15.3K 0.07% 163
2022
Q2 		$59K Hold
122
– – 0.05% 189
2022
Q1 		$60K Buy
+122
New +$55.8K 0.04% 198

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Riverview Trust Company's ELV Position: Q2 2025 in Review

Riverview Trust Company sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 72 shares — an estimated $31.3K sold.

Riverview Trust Company first reported a position in ELV in Q1 2022 and held it in 12 quarters. The position peaked at $93K in Q4 2022. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Riverview Trust Company reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Riverview Trust Company sold 72 Elevance Health shares in Q2 2025, an estimated $31.3K.
  • Riverview Trust Company first reported a position in Elevance Health in Q1 2022 and held it in 12 quarters.
  • Riverview Trust Company's Elevance Health position peaked at $93K in Q4 2022.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Riverview Trust Company's 13F filing for Q2 2025, filed 21 Jul 2025.